Real-world evidence on the risk of cancer with anti-IL-5 and anti-IL-4Ra
biologicals
- Diogo Mota,
- Tiago Rama,
- André Moreira
André Moreira
Centro Hospitalar Universitario de Sao Joao
Author Profile01 Aug 2022Submitted to Allergy 01 Aug 2022Submission Checks Completed
01 Aug 2022Assigned to Editor
03 Aug 2022Reviewer(s) Assigned
26 Aug 2022Review(s) Completed, Editorial Evaluation Pending
12 Dec 20221st Revision Received
12 Dec 2022Submission Checks Completed
12 Dec 2022Assigned to Editor
12 Dec 2022Review(s) Completed, Editorial Evaluation Pending
20 Dec 2022Editorial Decision: Accept
